Aminoglycoside antibacterials response
- Synonyms
- Aminoglycoside response
Summary
Excerpted from the GeneReview:Mitochondrial nonsyndromic hearing loss and deafness is characterized by sensorineural hearing loss (SNHL) of variable onset and severity. Pathogenic variants in MT-RNR1 can be associated with predisposition to aminoglycoside ototoxicity and/or late-onset SNHL. Hearing loss associated with aminoglycoside ototoxicity is bilateral and severe to profound, occurring within a few days to weeks after administration of any amount (even a single dose) of an aminoglycoside antibiotic such as gentamycin, tobramycin, amikacin, kanamycin, or streptomycin. Pathogenic variants in MT-TS1 are usually associated with childhood onset of SNHL that is generally nonsyndromic – although the MT-TS1 substitution m.7445A>G has been found in some families who also have palmoplantar keratoderma (scaling, hyperkeratosis, and honeycomb appearance of the skin of the palms, soles, and heels).
- Full text of GeneReview (by section):
- Summary
- Diagnosis
- Clinical Characteristics
- Genetically Related (Allelic) Disorders
- Differential Diagnosis
- Management
- Genetic Counseling
- Resources
- Molecular Genetics
- Chapter Notes
- References
- Authors:
- Shin-ichi Usami
- Shin-ya Nishio
- view full author information
Available tests
2 tests are in the database for this condition.
Check Related conditions for additional relevant tests.
Clinical tests (2 available)
Molecular Genetics Tests
- DailyMed Drug Label, 2013DailyMed Drug Label, STREPTOMYCIN, 2013
- DailyMed Drug Label, 2013DailyMed Drug Label, TOBRAMYCIN, 2013
- DailyMed Drug Label, 2013DailyMed Drug Label, AMIKACIN, 2013
- DailyMed Drug Label, 2012DailyMed Drug Label, GENTAMICIN, 2012
- DailyMed Drug Label, 2012DailyMed Drug Label, KANAMYCIN, 2012
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.